Company news
Certara, Inc. (NASDAQ:CERT) news
Every Certara, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Certara Reports Second Quarter 2026 Financial Results
August 4, 2026
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
July 15, 2026
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
July 7, 2026
Certara Announces CFO Transition
June 17, 2026
Certara Reports First Quarter 2026 Financial Results
May 11, 2026
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
May 7, 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
April 22, 2026
Cerrado Gold Announces Q1 2026 Production Results at Its Minera Don Nicolas Mine in Argentina
April 20, 2026
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
April 9, 2026
Cerrado Gold Announces Q4 and Annual 2025 Financial Results
April 2, 2026
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
March 3, 2026
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
February 26, 2026
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
January 29, 2026
Cerrado Gold Announces Tacit Approval of Environmental Impact Assessment for the Lagoa Salgada Project, Portugal
January 22, 2026
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
Certara Reports Third Quarter 2025 Financial Results
November 6, 2025
Certara Automates Scientific Workflows with Phoenix® Cloud
November 4, 2025
Certara to Participate in Upcoming November 2025 Investor Conferences
November 3, 2025
Certara to Participate in Upcoming Investor Conferences
October 31, 2025
Certara Expands Biosimulation Market with AI-Driven QSP Platform
October 30, 2025
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
October 10, 2025
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
September 4, 2025
Certara Reports Second Quarter 2025 Financial Results
August 6, 2025
Certara Reports Second Quarter 2025 Financial Results
August 6, 2025
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
August 4, 2025
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
July 31, 2025
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
July 9, 2025
Certara Announces Expansion of Clinical Technology Collaboration with Merck
July 8, 2025
Certara Reports First Quarter 2025 Financial Results
May 5, 2025
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
April 14, 2025
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
April 14, 2025
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 1, 2025
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
March 5, 2025
Certara Reports Fourth Quarter 2024 Financial Results
February 26, 2025
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Confere...
January 29, 2025
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
Certara Showcases 2024 Research Wins With Over 100 Papers Published
December 2, 2024
Certara Reports Third Quarter 2024 Financial Results
November 6, 2024
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
October 9, 2024
Certara Completes Acquisition of Chemaxon
October 2, 2024
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
Certara Reports Second Quarter 2024 Financial Results
August 6, 2024
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 9, 2024
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 2, 2024